Identification of an active metabolite of PAR-1 antagonist RWJ-58259 and synthesis of analogues to enhance its metabolic stabilityElectronic supplementary information (ESI) available: Full characterisation of all synthesised compounds. See DOI: 10.1039/c6ob00332j

The discontinuation of PAR-1 antagonist RWJ-58259 beyond use as a biological probe is most likely due to it's short half-life in vivo . However, retention of significant in vivo activity beyond the point where most of the RWJ-58259 had been consumed implies the generation of an active metabolit...

Full description

Saved in:
Bibliographic Details
Main Authors Robinson, Eifion, Knight, Emily, Smoktunowicz, Natalia, Chambers, Rachel C, Inglis, Graham G, Chudasama, Vijay, Caddick, Stephen
Format Journal Article
Published 15.03.2016
Online AccessGet full text

Cover

More Information
Summary:The discontinuation of PAR-1 antagonist RWJ-58259 beyond use as a biological probe is most likely due to it's short half-life in vivo . However, retention of significant in vivo activity beyond the point where most of the RWJ-58259 had been consumed implies the generation of an active metabolite. Herein we describe the biological activity of a predicted metabolite of RWJ-58259 and the synthesis of analogues designed to enhance the metabolic stability of RWJ-58259. Understanding the pharmacokinetic behaviour of PAR-1 antagonist RWJ-58259 and the synthesis of analogues to enhance metabolic stability.
Bibliography:Electronic supplementary information (ESI) available: Full characterisation of all synthesised compounds. See DOI
10.1039/c6ob00332j
ISSN:1477-0520
1477-0539
DOI:10.1039/c6ob00332j